AmreenMDinaniMD
Gastroenterology • Durham, NCHepatology & Liver Transplantation
Associate Professor of Medicine, Duke University
Dr. Dinani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
40 Duke Medicine Circle Clinic 2J
Durham, NC 27710Phone+1 919-681-3180
Education & Training
New York-Presbyterian/QueensResidency, Internal Medicine, 2006 - 2009
American University of the Caribbean School of MedicineClass of 2005
Certifications & Licensure
NH State Medical License 2013 - Present
NC State Medical License 2022 - 2025
NY State Medical License 2016 - 2023- American Board of Internal Medicine Gastroenterology
- American Board of Obesity Medicine Obesity Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 11 citationsIntegrated Hepatitis C-Opioid Use Disorder Care Through Facilitated Telemedicine: A Randomized Trial.Andrew H Talal, Marianthi Markatou, Anran Liu, Ponni V Perumalswami, Amreen M Dinani
JAMA. 2024-04-23 - 2 citationsImmunosuppression management for refractory checkpoint inhibitor-related hepatotoxicity.Gres Karim, Megha Reddy, Navim Mobin, Ilan Weisberg, Amreen Dinani
Clinical Liver Disease. 2024-01-19 - Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease Is Independently Associated With Reduced Renal Function.Carolina Villarroel, Gres Karim, Mantej Sehmbhi, Jake Debroff, Ilan Weisberg
Gastro Hep Advances. 2024-01-01
Press Mentions
NASHNET Celebrates International NASH Day with an Educational Podcast SeriesJune 12th, 2020
Rox Heart Radio: From the Front with Amreen DinaniMay 20th, 2020- JAMA Paper: In People with Opioid Use Disorder, Telemedicine Treatment for HCV Was More Than Twice as Successful as off-Site ReferralApril 9th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
